Vol 12, No 12 (December 31, 2023): Translational Cancer Research

Editorial Commentary

Tackling the HuRdle of radioresistance: a radiation perspective on the RNA-binding protein HuR
Fabian M. Troschel, Hans Theodor Eich, Burkhard Greve
Translational Cancer Research  
2023;
12
(12)
:3223-3226
.
KRAS G12C inhibitors: also a new promising new targeted therapy in advanced pancreatic adenocarcinoma?
Marie Muller, David Tougeron
Translational Cancer Research  
2023;
12
(12)
:3227-3232
.
The growing role of PARP inhibitors in the treatment of metastatic castration-resistant prostate cancer
John Panzone, Gavrielle J. Rood, Hanan Goldberg
Translational Cancer Research  
2023;
12
(12)
:3233-3240
.
Angiogenesis inhibitors for metastatic colorectal cancer
Per Pfeiffer, Gabor Liposits, Line Schmidt Taarpgaard
Translational Cancer Research  
2023;
12
(12)
:3241-3244
.
Unraveling the puzzle: efficacy of PD-L1 inhibitors in esophageal squamous cell carcinomas with low PD-L1 expression—a comprehensive overview of challenges and limitations
Suhaib El Khatib, Anwaar Saeed
Translational Cancer Research  
2023;
12
(12)
:3245-3248
.
Phytochemicals as estrogen receptor modulators?—a commentary of a network pharmacology study of two commonly employed Chinese herbal medicines in non-small cell lung cancer treatment
Claudia Beatriz Hereñú, Rosana Crespo
Translational Cancer Research  
2023;
12
(12)
:3249-3254
.

Original Article

Advantages of IMRT optimization with MCO compared to IMRT optimization without MCO in reducing small bowel high dose index for cervical cancer patients—individualized treatment options
Zejun Jiang, Gongsen Zhang, Tao Sun, Guifang Zhang, Xinqiang Zhang, Xiangyue Kong, Yong Yin
Translational Cancer Research  
2023;
12
(12)
:3255-3265
.
Identification of enhancer RNA AC005515.1 as a novel biomarker for prognosis in esophageal cancer and predictors of immunotherapy response
Lihua Jia, Jianghua Chen, Jia Zhao, Junbao Yang
Translational Cancer Research  
2023;
12
(12)
:3266-3283
.
Predictive nomograms for risk and prognostic factors in metastatic bladder cancer: a population-based study
Shuibo Shi, Guangbei Peng, Longhua Luo, Dongshui Li
Translational Cancer Research  
2023;
12
(12)
:3284-3302
.
Effect of neoadjuvant endocrine therapy on the acoustic environment in tissue of prostate cancer: a study of histopathological characteristics
Longquan Zou, Wei Chen, Guangqing Fu, Dengjun Han, Xiang Zeng, Cai Zhang, Xiaobo Gong, Hong Liu, Jianhui Liu, Zhibiao Wang, Yong Liang, Haoran Huang
Translational Cancer Research  
2023;
12
(12)
:3303-3313
.
Competing risk analysis of cardiovascular mortality in multiple myeloma survivors
Ganxiao Chen, Hongdou Guo, Jiayi Lin, Shunxiang Luo, Shanghua Xu
Translational Cancer Research  
2023;
12
(12)
:3314-3326
.
Identification of cuproptosis and ferroptosis-related subgroups and development of a signature for predicting prognosis and tumor microenvironment landscape in hepatocellular carcinoma
Bin-Feng Yang, Qi Ma, Yuan Hui, Xiang-Chun Gao, Da-You Ma, Jing-Xian Li, Zheng-Xue Pei, Bang-Rong Huang
Translational Cancer Research  
2023;
12
(12)
:3327-3345
.
Analysis of prognostic factors and establishment of prediction model of lung adenocarcinoma based on SEER database
Jiahui He, Qinyong Hu
Translational Cancer Research  
2023;
12
(12)
:3346-3359
.
Expression of pyroptosis-associated genes and construction of prognostic model for thyroid cancer
Lin Guo, Min Yuan, Senhe Jiang, Gang Jin, Ping Li
Translational Cancer Research  
2023;
12
(12)
:3360-3383
.
New insights into COL26A1 in thyroid carcinoma: prognostic prediction, functional characterization, immunological drug target and ceRNA network
Yulou Luo, Yinghui Ye, Yuting Zhang, Lan Chen, Ximing Qu, Na Yi, Jihua Ran, Yan Chen
Translational Cancer Research  
2023;
12
(12)
:3384-3408
.
The identification of a PTEN-associated gene signature for the prediction of prognosis and planning of therapeutic strategy in endometrial cancer
Yuan Zhang, Li Li, Xiao-Ping Ke, Ping Liu
Translational Cancer Research  
2023;
12
(12)
:3409-3424
.
Initial experience in robot-associated radical nephrectomy with inferior vena cava tumor thrombectomy
Kojiro Ohba, Kensuke Mitsunari, Hiromi Nakanishi, Takuji Yasuda, Yuichiro Nakamura, Tomohiro Matsuo, Yasushi Mochizuki, Ryoichi Imamura
Translational Cancer Research  
2023;
12
(12)
:3425-3431
.
A nomogram based on clinical features and molecular abnormalities for predicting the prognosis of patients with acute myeloid leukemia
Yuancheng Guo, Yujie Niu, Haiping Liang, Xiaoxiao Yang, Jinli Jian, Xiao Tang, Bei Liu
Translational Cancer Research  
2023;
12
(12)
:3432-3442
.
ARHGEF16 expression correlates with proliferation, migration and invasion of colon cancer cells
Mengmeng Liu, Dong Xu, Baocheng Zhu, Chao Song, Qianzhi Ni, Zhenjun Gao
Translational Cancer Research  
2023;
12
(12)
:3443-3452
.
A model for predicting clinical prognosis based on brain metastasis-related genes in patients with breast cancer
Jiangwei Yuan, Jianfeng Li, Zhenxiang Zhao
Translational Cancer Research  
2023;
12
(12)
:3453-3470
.
Machine-learning methods based on the texture and non-texture features of MRI for the preoperative prediction of sentinel lymph node metastasis in breast cancer
Jian Wang, Xinna Gao, Shuixing Zhang, Yu Zhang
Translational Cancer Research  
2023;
12
(12)
:3471-3485
.
Noval ceRNA axis-mediated high expression of TOP2A correlates with poor prognosis and tumor immune infiltration of hepatocellular carcinoma
Yang Wang, Xiao-Qing Wang, Li-Li Li, Peng Lou, Qian Zhang
Translational Cancer Research  
2023;
12
(12)
:3486-3502
.
HTRA1 expression is associated with immune-cell infiltration and survival in breast cancer
Dawei Zhao, Wanfeng Li, Yan Wang, Gengyue Zhang, Xinhua Bai, Hong Yu
Translational Cancer Research  
2023;
12
(12)
:3503-3521
.
Robot-assisted radical nephroureterectomy for upper urinary tract tumor: initial experience with the use of novel surgical robot system, hinotori
Daisuke Motoyama, Yuto Matsushita, Hiromitsu Watanabe, Keita Tamura, Atsushi Otsuka, Masato Fujisawa, Hideaki Miyake
Translational Cancer Research  
2023;
12
(12)
:3522-3529
.
Correlation between 18-FDG standardized uptake value and tumor grade in patients with resectable non-small cell lung cancer
Błażej Kużdżał, Konrad Moszczyński, Katarzyna Żanowska, Jolanta Hauer, Sofiia Popovchenko, Monika Bryndza, Janusz Warmus, Łukasz Trybalski, Lucyna Rudnicka, Piotr Kocoń
Translational Cancer Research  
2023;
12
(12)
:3530-3537
.
Predictors of central line-associated bloodstream infections in cancer patients undergoing chemotherapy through implanted venous access ports: a retrospective, observational study
Hao Chen, Takamasa Yamane, Terunobu Haruyama, Masashi Ishihara, Hiroki Kazahari, Takahiko Sakamoto, Shigeru Tanzawa, Takeshi Honda, Yasuko Ichikawa, Kiyotaka Watanabe, Nobuhiko Seki
Translational Cancer Research  
2023;
12
(12)
:3538-3546
.
Nomogram predicts risk and prognostic factors for lung metastasis of anaplastic thyroid carcinoma: a retrospective study in the Surveillance Epidemiology and End Results (SEER) database
Jinzhe Bi, Hao Zhang
Translational Cancer Research  
2023;
12
(12)
:3547-3564
.
A novel prognostic and therapeutic target biomarker based on complement-related gene signature in gastric cancer
Zuming Liu, Mingwei Yang, Hang Shu, Jianmei Zhou
Translational Cancer Research  
2023;
12
(12)
:3565-3580
.
Use of survival support vector machine combined with random survival forest to predict the survival of nasopharyngeal carcinoma patients
Zhiwei Xiao, Qiong Song, Yuekun Wei, Yong Fu, Daizheng Huang, Chao Huang
Translational Cancer Research  
2023;
12
(12)
:3581-3590
.
Competing risk analysis of cardiovascular death in breast cancer: evidence from the SEER database
Jiahui He, Shunde Wang, Hui Liu, Cheng Duan, Hao Zhang, Fei Wen, Chengsheng Zhang
Translational Cancer Research  
2023;
12
(12)
:3591-3603
.
Predicting therapeutic responses in head and neck squamous cell carcinoma from TP53 mutation detected by cell-free DNA
Mei Wei, Jingtai Zhi, Li Li, Wei Wang
Translational Cancer Research  
2023;
12
(12)
:3604-3617
.
The prognostic value of the controlling nutritional status (CONUT) score in predicting outcomes of esophageal cancer patients receiving radiotherapy with or without chemotherapy
Lele Chang, Xuemei Zhang, Qingwei Li
Translational Cancer Research  
2023;
12
(12)
:3618-3628
.
Identification of the function of FOSB in cholangiocarcinoma using bioinformatics analysis
Yihang Zhao, Hong Tang, Yaxian Kuai, Jianhua Xu, Bin Sun, Yang Li
Translational Cancer Research  
2023;
12
(12)
:3629-3640
.
KLRB1 is a novel prognostic biomarker in endometrial cancer and is associated with immune infiltration
Chunyun Liang, Yue Chen, Si Chen, Jingyao She, Qiuyan Shi, Peijuan Wang
Translational Cancer Research  
2023;
12
(12)
:3641-3652
.
A ten long noncoding RNA-based prognostic risk model construction and mechanism study in the basal-like immune-suppressed subtype of triple-negative breast cancer
Xiaoying Huang, Jinlong Huang, Qiuyan Huang, Shihao Zhou
Translational Cancer Research  
2023;
12
(12)
:3653-3671
.
Prognostic factors for hormone receptor-positive breast cancer with liver metastasis and establishment of novel nomograms for prediction: a SEER-based study
Zheng Xu, Yong Chen, Yi Dai, Yuxingzi Chen, Jinhua Ding
Translational Cancer Research  
2023;
12
(12)
:3672-3692
.
Establishment and validation of a prognostic immune-related lncRNA risk model for acute myeloid leukemia
Kun-Ying Xie, Shu-Zhao Chen, Yun Wang, Meng-Lan Zeng, Xiao-Ying Liu, Yang Liang, Jing Wei
Translational Cancer Research  
2023;
12
(12)
:3693-3702
.
Astragaloside IV enhances the sensitivity of breast cancer stem cells to paclitaxel by inhibiting stemness
Ping Huang, Huachao Li, Liping Ren, Haimei Xie, Liushan Chen, Yuqi Liang, Yuyu Hu, Heloisa Sobreiro Selistre-de-Araujo, Stergios Boussios, Sachin R. Jhawar, Rutao Cui, Qian Zuo, Qianjun Chen
Translational Cancer Research  
2023;
12
(12)
:3703-3717
.
Abnormal variation and prognostic significance of circulating immune cells in patients with nasopharyngeal carcinoma treated with chemoradiotherapy: a prospective cohort study
Chaoxiong Huang, Jianming Ding, Chuanzhong Huang, Ligen Yu, Imjai Chitapanarux, Michael Benedict A. Mejia, Zhaodong Fei, Chuanben Chen
Translational Cancer Research  
2023;
12
(12)
:3718-3727
.
Comprehensive analysis of HOX family genes in endometrial cancer
Lu Zhao, Weiming Lou, Yize Zhang, Yalan Han, Wei Zhang
Translational Cancer Research  
2023;
12
(12)
:3728-3743
.
Function and prognosis analysis of nucleolus protein DCAF13 in breast cancer
Mei Wang, Liang Fu, Jun Tian, Yongming Zhang, Lorenzo Rossi, Ke Wang
Translational Cancer Research  
2023;
12
(12)
:3744-3751
.
Suppression of hepatocellular carcinoma progression by long noncoding RNA apolipoprotein C1 pseudogene via the regulation of the microRNA-106b-PTEN axis
Yi Qian, Hao Chen, Liang Chen, Chuang Ge, Dongmei Zhu, Dinghua Zhou
Translational Cancer Research  
2023;
12
(12)
:3752-3763
.

Review Article

Clinical advances in EGFR-TKI combination therapy for EGFR-mutated NSCLC: a narrative review
Qianru Zhang, Ruo Wang, Lu Xu
Translational Cancer Research  
2023;
12
(12)
:3764-3778
.
Mechanisms and characteristics of subcapsular sinus macrophages in tumor immunity: a narrative review
Feng Su, Yutao Zhang, Subinuer Maimaiti, Shanglin Chen, Yaxing Shen, Mingxiang Feng, Zhiqiang Guo, Lijie Tan, Jie He
Translational Cancer Research  
2023;
12
(12)
:3779-3791
.

Case Report

Robot-assisted radical nephrectomy with inferior vena cava thrombectomy: a case report
Kiyoshi Takahara, Masashi Takenaka, Kenji Zennami, Takuhisa Nukaya, Manabu Ichino, Hitomi Sasaki, Makoto Sumitomo, Ryoichi Shiroki
Translational Cancer Research  
2023;
12
(12)
:3792-3798
.